Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis
Patrick Stelmach, Klaus Wethmar, Christoph Groth, Daniela V. Wenge, Jörn C. Albring, Jan‐Henrik Mikesch, Christoph Schliemann, Christian Reicherts, Wolfgang E. Berdel, Georg Lenz, Matthias Stelljes
Topics & Concepts
BlinatumomabMedicineInternal medicineSalvage therapyMinimal residual diseaseTransplantationRefractory (planetary science)GastroenterologyOncologyChemotherapyLeukemiaLymphoblastic LeukemiaPhysicsAstrobiologyAcute Lymphoblastic Leukemia researchCAR-T cell therapy researchChronic Myeloid Leukemia Treatments